In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Direct Flow Medical gets $27.1mm in financing

Executive Summary

Direct Flow Medical Inc. (developing transcatheter heart valves) raised $27.1mm in a late-stage financing to 11 investors. According the Form D, the company sold and issued Series A-1 preferred stock, Series AA preferred stock, convertible notes, warrants to purchase Series A-1 or preferred stock, Series A-1 or preferred stock upon exercise, and the underlying common stock issuable upon conversion. Direct Flow Medical's last fund-raise was in late-2014 through the sale of $17mm in Series C-1 preferred shares.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies